Mithra Pharmaceuticals (MITPF) Stock Price, News & Analysis

Company Overview

Mithra Pharmaceuticals is a Belgian biopharmaceutical company dedicated to the development and commercialization of products for women’s health. The company focuses on innovative solutions in contraception, menopause care, and hormone replacement therapy, leveraging its expertise in steroidal and non-steroidal compounds. Mithra’s research efforts center on selective estrogen receptor modulators and tissue-selective estrogen complexes designed to offer improved safety and tolerability profiles compared with traditional hormonal therapies.

Among its approved offerings is Estelle, a combined oral contraceptive that incorporates estetrol, a naturally occurring fetal estrogen, which is under registration in multiple European countries. Mithra’s pipeline includes novel candidates for menopause symptom relief and treatments for endometriosis, with several programs progressing through clinical development. The company also pursues strategic partnerships and licensing agreements to expand the reach of its contraceptive and hormone therapy products across global markets.

Founded in 1999 and headquartered in Liège, Belgium, Mithra Pharmaceuticals operates research and manufacturing facilities in Europe and maintains a commercial presence in key markets. The company’s team brings together expertise in medicinal chemistry, endocrinology and regulatory affairs to advance its portfolio. Through ongoing collaborations and clinical research, Mithra aims to address unmet needs in women’s health by delivering safer, science-driven therapies.

Key Stats

• Today's Range: $6.75 to $6.75
• 50-Day Range: $6.75 to $6.75
• 52-Week Range: $6.75 to $7.75
• Volume: N/A
• Average Volume: 1,600 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

MITPF Stock Analysis - Frequently Asked Questions

How have MITPF shares performed this year?

Mithra Pharmaceuticals' stock was trading at $6.75 at the beginning of 2025. Since then, MITPF stock has increased by 0.0% and is now trading at $6.75.

How do I buy shares of Mithra Pharmaceuticals?

Shares of MITPF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Drug Manufacturers - Specialty & Generic
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:MITPF
• CIK: N/A
• Web: www.mithra.com
• Phone: 32 4 349 28 22
• Fax: N/A
• Employees: 270
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A